Inventor · disambiguated record
Bjorn Klasson
Also filed as: KLASSON BJORN · KLASSON BJÖRN
12 granted patents·6 pending applications·17 citations·filing 2010–2024
87Inventor score
Top patents by PatentIndex Score
18 records- 0193US11447511B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2020·Granted Sep 20, 2022·2 cites·11 claims
- 0289US10654877B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2019·Granted May 19, 2020·2 cites·12 claims
- 0388US10144750B2Dioxolane analogues of cytidine for the treatment of cancerMEDIVIR AB·Filed 2015·Granted Dec 4, 2018·6 cites·9 claims
- 0485US10336780B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2018·Granted Jul 2, 2019·3 cites·10 claims
- 0585US2023382931A1Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2023·Application pending·0 cites
- 0684US10822360B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2020·Granted Nov 3, 2020·1 cites·13 claims
- 0783US10456413B2Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug of troxacitabineMEDIVIR AB·Filed 2017·Granted Oct 29, 2019·2 cites·20 claims
- 0881US2023117570A1Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2022·Application pending·0 cites
- 0973US12479870B2Base-modified cytidine nucleotides for leukemia therapyMEDIVIR AB·Filed 2024·Granted Nov 25, 2025·0 cites·17 claims
- 1072US10960017B2Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination therapy for liver cancerMEDIVIR AB·Filed 2019·Granted Mar 30, 2021·1 cites·15 claims
- 1158US2014066398A1Hcv polymerase inhibitorsMEDIVIR AB·Filed 2013·Application pending·0 cites
- 1249US2013143835A1HCV Polymerase InhibitorsMEDIVIR AB·Filed 2012·Application pending·0 cites
- 1346US2021261584A1Base-Modified Cytidine Nucleotides for Leukemia TherapyMEDIVIR AB·Filed 2019·Application pending·0 cites
- 1445US12221459B2Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotidesMEDIVIR AB·Filed 2019·Granted Feb 11, 2025·0 cites·26 claims
- 1543US2015025250A1Cysteine protease inhibitorsMEDIVIR UK LTD·Filed 2014·Application pending·0 cites
- 1640US8859505B2Cysteine protease inhibitorsAYESA SUSANA·Filed 2011·Granted Oct 14, 2014·0 cites·22 claims
- 1738US8859605B2Cysteine protease inhibitorsAYESA SUSANA·Filed 2010·Granted Oct 14, 2014·0 cites·15 claims
- 1838US8815809B2Cysteine protease inhibitorsAYESA SUSANA·Filed 2010·Granted Aug 26, 2014·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Bjorn Klasson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →